Cellosaurus cell line 1180-mel (CVCL

Cellosaurus 1180-mel (CVCL_GR80)

Cross-references
Cell line name	1180-mel
Synonyms	1180-MEL; 1180mel; 1180MEL
Accession	CVCL_GR80
Resource Identification Initiative	To cite this cell line use: 1180-mel (RRID:CVCL_GR80)
Comments	From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA. Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
Sequence variations	Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Unspecified (PubMed=15661905).
Disease	Melanoma (NCIt: C3224)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Female
Age at sampling	46Y
Category	Cancer cell line
Publications	PubMed=8537970; DOI=10.1093/jnci/88.2.100; PMCID=PMC2248456 Nicholas P. Restifo, Francesco M. Marincola, Yutaka Kawakami, Jeffery Karl Taubenberger, John R. Yannelli, Steven A. Rosenberg; Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J. Natl. Cancer Inst. 88:100-108(1996) PubMed=15661905; DOI=10.4049/jimmunol.174.3.1462; PMCID=PMC2245899 Chien-Chung Chang, Michael Campoli, Nicholas P. Restifo, Xin-Hui Wang, Soldano Ferrone; Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy. J. Immunol. 174:1462-1471(2005)
Cell line databases/resources	TOKU-E; 4039
Encyclopedic resources	Wikidata; Q54581027
Polymorphism and mutation databases	Cosmic; 2759881
Entry history
Entry creation	26-Sep-2016
Last entry update	19-Dec-2024
Version number	11